<amendment session="112" chamber="s" number="2111" updated="2013-07-19T20:24:16-04:00">
  <amends type="s" number="3187" sequence=""/>
  <status datetime="2012-05-24">fail</status>
  <sponsor id="300009"/>
  <offered datetime="2012-05-17"/>
  <description>To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.</description>
  <actions>
    <action datetime="2012-05-24">
      <text>Amendment SA 2111 proposed by Senator Bingaman.</text>
      <reference ref="CR S3542-3543, S3547-3548, S3553-3554" label="consideration"/>
    </action>
    <vote datetime="2012-05-24" how="roll" result="fail" roll="105">
      <text>Amendment SA 2111, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 28 - 67. Record Vote Number: 105.</text>
    </vote>
  </actions>
</amendment>
